Portland, OR, Feb. 26, 2019 (GLOBE NEWSWIRE) -- The global Regenerative Medicine Market was valued at USD 5,444 million in 2016, and is estimated to reach USF 39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. North America was the highest contributor in the regenerative medicine market in 2016. Asia-Pacific is expected to grow with a highest CAGR during the forecast period.
A Sample Copy of this Research Report available at: https://www.bigmarketresearch.com/request-sample/20124?utm_source=GNW&utm_medium=CC
The global regenerative medicine market is segmented based on product type, material, application, and region. Based on product type, the market is segmented into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Depending on material, the market is divided into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. Synthetic material is further divided into biodegradable synthetic polymer, scaffold, artificial vascular graft material, and hydrogel material. Biologically derived material is further bifurcated into collagen and xenogenic material. Genetically engineered material is further segmented into deoxyribonucleic acid, transfection vector, genetically manipulated cell, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceutical is further divided into small molecule and biologic. By application, it is categorized into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic Plc., Athersys, Inc., U.S. Stem Cell, Inc. (Bioheart, Inc.), Organogenesis, Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Isto Biologics (Isto Biologics Medical Systems, Inc.), and CryoLife, Inc.
Inquiry before Order this Premium Research Report: https://www.bigmarketresearch.com/purchase-enquiry/20124?utm_source=GNW&utm_medium=CC
Related Report:
Stem Cell Banking Market: Global Opportunity Analysis and Industry Forecast, 2017 – 2023
Soft Tissue Repair Market: Global Opportunity Analysis and Industry Forecast, 2017-2025
About Us:
Big Market Research has a range of research reports in different domains across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.